Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial

The aim of this study is to inform and improve future clinical trials in Wilson Disease (WD) by better understanding how patients with WD are living with and managing the disease, and by identifying key factors that shape their decisions to participate in clinical research.

NCT Number	NCT07226622
Lead Sponsor	Prime Medicine, Inc.
Conditions	Wilson Disease
Enrollment	30 participants
Start Date	2025-12-29
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-12